JP Morgan Initiates Neurocrine Biosciences With Overweight By: Benzinga via Benzinga March 19, 2015 at 09:18 AM EDT Analysts at JP Morgan initiated coverage on Neurocrine Biosciences Inc. (NASDAQ: NBIX) with a Overweight rating. The target price for ... Read More >> Related Stocks: Neurocrine Bioscienc